Health Novo Nordisk Price Cuts: Will They Expand Access to Ozempic & Wegovy?
Novo Nordisk Cuts Prices of Ozempic, Wegovy, and Rybelsus Novo Nordisk announced significant price reductions for its popular GLP-1 medications – Ozempic,…
News Desk
STAT+
Latest reporting, analysis and developments from this news desk.
Health 
Health Hims & Hers Earnings: GLP-1 Scrutiny & Future Growth Plans
Hims & Hers Faces Scrutiny as FDA Cracks Down on Compounded GLP-1 Drugs Direct-to-consumer telehealth company Hims & Hers Health is navigating…
Health FDA Scrutiny, Antibiotic Sale & Weekend Plans: Healthcare & Life Updates
FDA to Increase Scrutiny of Antidepressants and RSV Immunizations; Antibiotic Supply Chain Faces Challenges The U.S. Food and Drug Administration (FDA) is…
Health OhioHealth Sued by DOJ for Alleged Anti-Competitive Practices
DOJ and Ohio Sue OhioHealth Over Antitrust Concerns The Department of Justice (DOJ) and the state of Ohio have filed a civil…
Health Cancer Immunotherapy Study Faces Data Integrity Concerns
Study Linking Morning Immunotherapy to Improved Lung Cancer Outcomes Faces Scrutiny A recent study published in Nature Medicine suggesting that the timing…
Health Pharma & Biotech Moves: CDR-Life Hires New CMO | STAT News
CDR-Life Appoints Dimitrios Chondros as Chief Medical Officer Zürich, Switzerland – February 3, 2026 – CDR-Life, Inc., a clinical-stage biotechnology company focused…
Health Texas Sues Sanofi Over Alleged Kickback Scheme to Doctors
Sanofi Sued by Texas Attorney General Over Alleged Kickback Scheme Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant…
Health Mario Aguilar: Health Tech & Digital Health News | STAT News
Mario Aguilar: STAT's Health Tech Correspondent Mario Aguilar is a health tech correspondent at STAT, a leading publication covering health, medicine, and…
Health NIH Director Bhattacharya to Lead CDC on Acting Basis
NIH Director Jay Bhattacharya to Lead CDC Temporarily Amidst Leadership Changes WASHINGTON — Dr. Jay Bhattacharya, Director of the National Institutes of…
Health RFK Jr. Team Divided on Pharma & Vaccines at PhRMA Forum
RFK Jr.'s HHS Leadership Shows Divergent Views on Pharma Regulation Washington D.C. – A recent forum hosted by the Pharmaceutical Research and…
Health Ocular Therapeutix’s Axpaxli Shows Promise in Macular Degeneration Trial, But Results Mixed
Ocular Therapeutix’s Axpaxli Shows Promise in Wet AMD Treatment, Challenging Eylea A new experimental eye drug, Axpaxli, developed by Ocular Therapeutix, has…
Health Medicare Advantage Enrollment Growth Slows to 3% – STAT News
Medicare Advantage Growth Slows for Second Year, Raising Questions About Future of Popular Plans Medicare Advantage, a popular alternative to traditional Medicare,…
Health RFK Jr. to Tackle Ultra-Processed Foods Following FDA Petition
Kennedy Administration to Address Concerns Over Ultra-Processed Foods Health and Human Services Secretary Robert F. Kennedy Jr. Has announced plans to take…
Health CDC Directorless: Trump Administration & Public Health Concerns
RFK Jr.’s Tenure at HHS Marked by CDC Leadership Turmoil The recent firing of Susan Monarez as director of the Centers for…
Health FDA Rejects Disc Medicine Drug – Early Voucher Recipient
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He…
Health STAT+: Comings and Goings in the Industry News
Lexeo Therapeutics Appoints Narinder Bhalla as Chief Medical Officer Lexeo Therapeutics has announced the appointment of Narinder Bhalla, MD, as its new…
Health Moderna President Comments on FDA’s Flu Vaccine Delay
Food and Drug Administration officials told Moderna in August that they would review its application for a new influenza vaccine, reiterating guidance…
Health Trump Administration ACA Plans: Cheaper, But Skimpier
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes…